بحث بيانات أعضاء هيئة التدريس - جامعة الزقازيق

/ بحث بيانات أعضاء هيئة التدريس - جامعة الزقازيق

لايوجد

الموقع الشخصى
السيرة الذاتية

هاني محمد عبدالملك محمود الباسوسى

الكلية الصيدلة - القسم علم الادوية والسموم
الاقربازين والفارماكولوجي

وكيل الكلية للدراسات العليا

الدرجات العلمية

بكالوريوس فى الاقربازين والفارماكولوجي, -جامعة الزقازيق [1998]
ماجستير فى الاقربازين والفارماكولوجي, -جامعة الزقازيق [2003]
(لا يوجد)
دكتوراه فى الاقربازين والفارماكولوجي, -جامعة الزقازيق [2008]
(لا يوجد)

الحالة الوظيفية الحالية :

قائم بالعمل

التدرج الوظيفى الأكاديمى

معيد : 16/9/1998
مدرس مساعد : 21/12/2002
مدرس : 29/4/2008
أستاذ مساعد : 24/6/2013
أستاذ : 25/9/2018

الأبحاث العلمية

1 - Arginase inhibition alleviates hypertension in the metabolic syndrome (1434).

2 - Heme oxygenase-1 induction protects against hypertension associated with diabetes: effect on exaggerated vascular contractility (1434).

3 - Chrysin and Luteolin Attenuate Diabetes-Induced Impairment in Endothelial-Dependent Relaxation: Effect on Lipid Profile, AGEs and NO Generation (1434).

4 - Aldose reductase inhibitors, zopolrestat and ferulic acid, alleviate hypertension associated with diabetes: Effect on vascular reactivity (1434).

5 - Phenolics from Garcinia mangostana alleviate exaggerated vasoconstriction in metabolic syndrome through direct vasodilatation and nitric oxide generation (1438).

6 - Cardioprotection by 6-gingerol in diabetic rats (1437).

7 - Geraniol improves the impaired vascular reactivity in diabetes and metabolic syndrome through calcium channel blocking effect (1437).

8 - Gingerol Synergizes the Cytotoxic Effects of Doxorubicin against Liver Cancer Cells and Protects from Its Vascular Toxicity (1437).

9 - Protective effect of zingerone on increased vascular contractility in diabetic rat aorta (1437).

10 - Phenolics from Garcinia mangostana Inhibit Advanced Glycation Endproducts Formation: Effect on Amadori Products, Cross-Linked Structures and Protein Thiols (1437).

11 - PARP-1 inhibition alleviates diabetic cardiac complications in experimental animals (1437).

12 - Zingerone alleviates the delayed ventricular repolarization and AV conduction in diabetes: Effect on cardiac fibrosis and inflammation (1439).

13 - Perinatal ciclosporin A exposure elicits sex-related cardiac dysfunction and inflammation in the rat progeny (1438).

14 - PARP inhibition ameliorates nephropathy in an animal model of type 2 diabetes: focus on oxidative stress, inflammation, and fibrosis (1438).

15 - Geraniol alleviates diabetic cardiac complications: Effect on cardiac ischemia and oxidative stress (1438).

16 - The inflammatory state provokes sexual dimorphism in left ventricular and electrocardiographic effects of chronic cyclosporine in rats (1438).

17 - Ginger Ingredients Alleviate Diabetic Prostatic Complications: Effect on Oxidative Stress and Fibrosis (1438).

18 - Pentoxifylline Alleviates Proteinuria in Fructose Model of Metabolic Syndrome (1439).

19 - Mangostanaxanthones III and IV: advanced glycation end-product inhibitors from the pericarp of Garcinia mangostana (1439).

20 - Effect of Viscum schimperi on advanced glycation endproducts formation (1438).

21 - Ferulic acid, a natural polyphenol, alleviates insulin resistance and hypertension in fructose fed rats: Effect on endothelial-dependent relaxation (1439).

22 - The possible antianginal effect of allopurinol in vasopressin-induced ischemic model in rats (1437).

23 - Allopurinol alleviates hypertension and proteinuria in high fructose, high salt and high fat induced model of metabolic syndrome (1436).

24 - Pentoxifylline alleviates hypertension in metabolic syndrome: effect on low-grade inflammation and angiotensin system (1436).

25 - Xanthine oxidase inhibition alleviates the cardiac complications of insulin resistance: effect on low grade inflammation and the angiotensin system (1436).

26 - Targeting AGEs Signaling Ameliorates Central Nervous System Diabetic Complications in Rats (1436).

27 - 6-Gingerol alleviates exaggerated vasoconstriction in diabetic rat aorta through direct vasodilation and nitric oxide generation (1436).

28 - Ameliorative Effect of Allopurinol on Vascular Complications of Insulin Resistance (1436).

29 - Characterization of vascular complications in experimental model of fructose-induced metabolic syndrome (1436).

30 - Heme oxygenase-1 alleviates vascular complications associated with metabolic syndrome: Effect on endothelial dependent relaxation and NO production (1436).

31 - Baicalein protects against hypertension associated with diabetes: Effect on vascular reactivity and stiffness (1435).

32 - Curcumin attenuates fructose-induced vascular dysfunction of isolated rat thoracic aorta rings (1435).

33 - Pentoxifylline Alleviates Cardiac Ischemia and Dysfunction Following Experimental Angina in Insulin Resistance (1435).

34 - Caffeic acid phenethyl ester, a 5-lipoxygenase enzyme inhibitor, alleviates diabetic atherosclerotic manifestations: Effect on vascular reactivity and stiffness (1435).

35 - Chrysin and Luteolin Alleviate Vascular Complications Associated with Insulin Resistance Mainly Through PPAR-gamma Activation (1435).

36 - Quercetin Protects against Diabetes-Induced Exaggerated Vasoconstriction in Rats: Effect on Low Grade Inflammation (1434).

37 - Arginase inhibition alleviates hypertension associated with diabetes: Effect on endothelial dependent relaxation and NO production (1433).

38 - Rosiglitazone, a peroxisome proliferator-activated receptor gamma stimulant, abrogates diabetes-evoked hypertension by rectifying abnormalities in vascular reactivity (1433).

39 - Anti-inflammatory Effect of Atorvastatin on Vascular Reactivity and Insulin Resistance in Fructose Fed Rats (1433).

40 - Cinnamaldehyde protects from the hypertension associated with diabetes (1432).

41 - Pentoxifylline alleviates vascular impairment in insulin resistance via TNF-alpha inhibition (1432).

42 - Haem oxygenase-1 induction protects against tumour necrosis factor alpha impairment of endothelial-dependent relaxation in rat isolated pulmonary artery (1430).

43 - PARP inhibition ameliorates nephropathy in an animal model of type 2 diabetes: focus on oxidative stress, inflammation, and fibrosis (1438).

44 - Geraniol alleviates diabetic cardiac complications: Effect on cardiac ischemia and oxidative stress (1438).

45 - Zingerone alleviates the delayed ventricular repolarization and AV conduction in diabetes: Effect on cardiac fibrosis and inflammation (1439).

46 - Limonin alleviates macro- and micro-vascular complications of metabolic syndrome in rats: A comparative study with azelnidipine. (1439).

47 - Ajwa Nanopreparation Prevents Doxorubicin-Associated Cardiac Dysfunction: Effect on Cardiac Ischemia and Antioxidant Capacity (1440).

48 - Psiadia punctulata major flavonoids alleviate exaggerated vasoconstriction produced by advanced glycation end products. (1441).

49 - Psiadia punctulata major flavonoids alleviate exaggerated vasoconstriction produced by advanced glycation end products. (1441).

50 - Interference with AGEs formation and AGEs-induced vascular injury mediates curcumin vascular protection in metabolic syndrome (1441).

51 - Major flavonoids from Psiadia punctulata produce vasodilation via activation of endothelial dependent NO signaling (1441).

52 - Despite Blocking Doxorubicin-Induced Vascular Damage, Quercetin Ameliorates Its Antibreast Cancer Activity (1441).

53 - Modulation of preeclampsia by the cholinergic anti-inflammatory pathway: Therapeutic perspectives (1443).

54 - A Nano-Pharmaceutical Formula of Quercetin Protects from Cardiovascular Complications Associated with Metabolic Syndrome (1443).

55 - Nitric-Oxide-Mediated Vasodilation of Bioactive Compounds Isolated from Hypericum revolutum in Rat Aorta (1442).

56 - Interference with TGF beta 1-Mediated Inflammation and Fibrosis Underlies Reno-Protective Effects of the CB1 Receptor Neutral Antagonists AM6545 and AM4113 in a Rat Model of Metabolic Syndrome (1442).

57 - Self-Nanoemulsifying Drug Delivery System Loaded with Psiadia punctulata Major Metabolites for Hypertensive Emergencies: Effect on Hemodynamics and Cardiac Conductance (1442).

58 - Rp-HPLC Determination of Quercetin in a Novel D-alpha-Tocopherol Polyethylene Glycol 1000 Succinate Based SNEDDS Formulation: Pharmacokinetics in Rat Plasma (1442).

59 - Investigation of Alogliptin-Loaded In Situ Gel Implants by 23 Factorial Design with Glycemic Assessment in Rats (1444).

60 - Hinokitiol produces vasodilation in aortae from normal and angiotensin II- induced hypertensive rats via endothelial-dependent and independent pathways (1443).

61 - Hinokitiol for hypertensive emergencies: effects on peripheral resistance, cardiac load, baroreflex sensitivity, and electrolytes balance (1444).

62 - Development of depot PLGA-based in-situ implant of Linagliptin: Sustained release and glycemic control (1444).

63 - Rosuvastatin, but not atorvastatin, enhances the antihypertensive effect of cilostazol in an acute model of hypertension (1445).

64 - " تحسين ضغط الدم المرتفع الناتج عن مرض السكري بواسطة بعض المكونات الطبيعية " " Amelioration of diabetic hypertension by some natural ingredients (1445).

65 - " إستهداف انزيم الليبواوكسي جيناز كاستراتيجية محتملة لعلاج تصلب الشرايين المصاحب لمرض السكري " (1445).

66 - Sustained linagliptin administration: superior glycemic control and less pancreatic injury in diabetic rats (1446).

67 - Polymeric linagliptin nanoparticles as a sustained release treatment for type 2 diabetes (1445).

68 - Statins boost beneficial pleiotropic cardiovascular effects of cilostazol in angiotensin-II hypertensive rats

المجالات البحثية